Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Endologix takes AAA (abdominal aortic aneurysms) graft to China:

This article was originally published in Clinica

Executive Summary

China has given Endologix the all clear to market its PowerLink stent graft for the minimally invasive treatment of abdominal aortic aneurysms (AAA). The firm has begun shipping the product to physician training centres through its local distributor, Advanced Medical China. "We see a significant opportunity in China with that country's emerging middle class," said Paul McCormick, Endologix' president and CEO. In addition, the Irvine, California firm believes it will be the first to introduce a minimally invasive AAA treatment in Japan, where data from a completed trial of the product have already been filed.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT062013

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel